Forward Pharma Reports Full-Year 2017 Financial and Operational Results
April 30, 2018 16:40 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, April 30, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (Nasdaq:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the year ended December 31, 2017....
Forward Pharma to Present at the 7th Annual Leerink Partners Global Healthcare Conference
February 07, 2018 07:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will give a...
Forward Pharma Announces the Decision of the European Patent Office in the Opposition Proceedings for the EP2801355 Patent
January 29, 2018 10:44 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Jan. 29, 2018 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced that the European Patent Office (the “EPO”) has revoked the...
Forward Pharma Files Final Brief in its Appeal of the U.S. Patent Interference to the Federal Circuit
December 21, 2017 17:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Dec. 21, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing of its reply brief to the U.S. Court of Appeals for the...
Forward Pharma Files Further Written Submissions in the European Opposition Proceeding for the EP2801355 Patent in Preparation for the Oral Hearing in January 2018
November 29, 2017 16:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 29, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing of further written submissions in the European...
Forward Pharma to Participate in Investor Conferences in December
November 27, 2017 07:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 27, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
Forward Pharma Announces Completion of Corporate Restructuring Plan
November 22, 2017 16:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 22, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward Pharma”) today announced the completion of its previously announced corporate restructuring plan (the...
Forward Pharma to Participate in the Nordic-American Life Science Conference
November 09, 2017 16:30 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (the “Company”) today announced that Dr. Claus Bo Svendsen, the Company’s Chief Executive Officer, will...
Forward Pharma Reports Financial and Operational Results from the First Six Months of 2017
September 26, 2017 16:15 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 26, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“We” or “Forward” or the “Company”), today reported financial results for the six-month period ended June 30,...
Forward Pharma Files Opening Brief in the Appeal of the U.S. Patent Interference to the Federal Circuit
September 05, 2017 17:00 ET
|
Forward Pharma A/S
COPENHAGEN, Denmark, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”) today announced the filing in the U.S. Court of Appeals for the Federal Circuit...